Table 1

Baseline Characteristics According to the Level of Renal Function

eGFR (ml/min/1.73 m2)p Value
≤60 (n = 73)>60 (n = 573)
Age, yrs68.2 ± 10.857.6 ± 11.0<0.0001
Male58.977.80.0004
Diabetes mellitus24.716.50.08
White race93.392.51.00
Body mass index, kg/m229.8 ± 5.228.8 ± 5.60.01
Prior myocardial infarction11.09.80.76
Congestive heart failure5.51.60.05
History of angina20.923.40.65
Family history of coronary artery disease42.245.00.67
Hypertension requiring medication72.643.5<0.0001
Hypercholesterolemia requiring medication55.442.90.057
History of tobacco use within 1 month34.350.30.01
Prior cardiac intervention15.110.80.28
Statin use on admission34.245.50.07
Clinical presentation
 STEMI beyond 24 h16.430.20.01
 Non-STEMI79.566.10.02
 Unstable angina4.13.70.75
eGFR, ml/min/1.73 m251.7 ± 6.991.8 ± 21.5<0.0001
Total cholesterol169.5 ± 43.0176.1 ± 42.40.13
HDL-cholesterol41.6 ± 15.141.1 ± 13.00.61
LDL-cholesterol93.4 ± 39.4106.7 ± 36.30.003
Triglycerides181.1 ± 161.4149.3 ± 95.40.46
Fasting plasma glucose110.4 ± 30.8110.0 ± 33.00.70
C-reactive protein17.90 ± 31.3818.10 ± 29.700.92
Number of angiographic lesions per patient2.81 ± 2.092.52 ± 1.900.23
3-vessel coronary artery disease34.228.90.34

Values are mean ± SD or %.

eGFR = estimated glomerular filtration rate; HDL = high-density lipoprotein; LDL = low-density lipoprotein; STEMI = ST-segment elevation myocardial infarction.

  • Nonculprit lesions with diameter stenosis >30% by visual estimation.